Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Cancer Immunology Research|November 20, 2021
B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer ProgressionTaito Miyamoto, Ryusuke Murakami, Junzo Hamanishi, et al.Cancer Immunology, Immunotherapy : CII|February 7, 2026
Digital spatial profiling reveals additive effects of triple therapy on tumor microenvironment: anti-PD-L1, anti-VEGF, and PARP inhibition in mouse modelsAkihiko Ueda, Ryusuke Murakami, Kentaro Ishida, et al.Cancer Immunology, Immunotherapy : CII|February 16, 2026
Title: AI-based quantification of tumor-infiltrating lymphocytes with integrative transcriptomics in ovarian clear cell carcinoma: JGOG3025-TR1/A1 studyKohei Hamada, Junzo Hamanishi, Akihiko Ueda, et al.Cancer Science|July 10, 2026
AI-Based Analysis of Tumor-Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025-A1 StudyKohei Hamada, Junzo Hamanishi, Noriomi Matsumura, et al.JCI Insight|May 13, 2022
CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancerMasayo Ukita, Junzo Hamanishi, Hiroyuki Yoshitomi, et al.Cancer Immunology, Immunotherapy : CII|February 1, 2025
Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancerHaruka Suzuki, Kohei Hamada, Junzo Hamanishi, et al.International Journal of Clinical Oncology|January 8, 2025
Prognostic significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in uterine carcinosarcomaAzusa Sakurai, Ken Yamaguchi, Kentaro Ishida, et al.Molecular Cancer Therapeutics|March 12, 2026
A novel CDK12 inhibitor induces homologous recombination deficiency to enhance PARP inhibitor efficacy in uterine serous carcinomaShunsuke Kawahara, Mana Taki, Junzo Hamanishi, et al.Carcinogenesis|March 30, 2022
Immunosuppressive tumor microenvironment in uterine serous carcinoma via CCL7 signal with myeloid-derived suppressor cellsYuka Mise, Junzo Hamanishi, Takiko Daikoku, et al.Journal for Immunotherapy of Cancer|June 3, 2026
Chemotherapy induces an IL1β-dependent neutrophil recruitment and activation that promote chemoresistance in metastatic ovarian cancerTaito Miyamoto, Yujie Ye, Marlaine M Soliman, et al.Pageof 8